The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban

Young Hoon Kim, Jaemin Shim, Chia Ti Tsai, Chun Chieh Wang, Gilbert Vilela, Sombat Muengtaweepongsa, Mohammad Kurniawan, Oteh Maskon, Li Fern Hsu, Thang Huy Nguyen, Kenneth Sim, A. John Camm

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)1309-1311
Number of pages3
JournalChest
Volume155
Issue number6
DOIs
Publication statusPublished - 1 Jun 2019
Externally publishedYes

Fingerprint

Atrial Fibrillation
Guidelines
Therapeutics
Rivaroxaban

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Kim, Y. H., Shim, J., Tsai, C. T., Wang, C. C., Vilela, G., Muengtaweepongsa, S., ... Camm, A. J. (2019). The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban. Chest, 155(6), 1309-1311. https://doi.org/10.1016/j.chest.2019.03.036

The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban. / Kim, Young Hoon; Shim, Jaemin; Tsai, Chia Ti; Wang, Chun Chieh; Vilela, Gilbert; Muengtaweepongsa, Sombat; Kurniawan, Mohammad; Maskon, Oteh; Hsu, Li Fern; Nguyen, Thang Huy; Sim, Kenneth; Camm, A. John.

In: Chest, Vol. 155, No. 6, 01.06.2019, p. 1309-1311.

Research output: Contribution to journalLetter

Kim, YH, Shim, J, Tsai, CT, Wang, CC, Vilela, G, Muengtaweepongsa, S, Kurniawan, M, Maskon, O, Hsu, LF, Nguyen, TH, Sim, K & Camm, AJ 2019, 'The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban', Chest, vol. 155, no. 6, pp. 1309-1311. https://doi.org/10.1016/j.chest.2019.03.036
Kim, Young Hoon ; Shim, Jaemin ; Tsai, Chia Ti ; Wang, Chun Chieh ; Vilela, Gilbert ; Muengtaweepongsa, Sombat ; Kurniawan, Mohammad ; Maskon, Oteh ; Hsu, Li Fern ; Nguyen, Thang Huy ; Sim, Kenneth ; Camm, A. John. / The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban. In: Chest. 2019 ; Vol. 155, No. 6. pp. 1309-1311.
@article{8732192beb7e4b15a35c5d205874f370,
title = "The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban",
author = "Kim, {Young Hoon} and Jaemin Shim and Tsai, {Chia Ti} and Wang, {Chun Chieh} and Gilbert Vilela and Sombat Muengtaweepongsa and Mohammad Kurniawan and Oteh Maskon and Hsu, {Li Fern} and Nguyen, {Thang Huy} and Kenneth Sim and Camm, {A. John}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.chest.2019.03.036",
language = "English",
volume = "155",
pages = "1309--1311",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban

AU - Kim, Young Hoon

AU - Shim, Jaemin

AU - Tsai, Chia Ti

AU - Wang, Chun Chieh

AU - Vilela, Gilbert

AU - Muengtaweepongsa, Sombat

AU - Kurniawan, Mohammad

AU - Maskon, Oteh

AU - Hsu, Li Fern

AU - Nguyen, Thang Huy

AU - Sim, Kenneth

AU - Camm, A. John

PY - 2019/6/1

Y1 - 2019/6/1

UR - http://www.scopus.com/inward/record.url?scp=85066016618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066016618&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2019.03.036

DO - 10.1016/j.chest.2019.03.036

M3 - Letter

C2 - 31174652

AN - SCOPUS:85066016618

VL - 155

SP - 1309

EP - 1311

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -